EDGAR Filing Documents for 0001104659-16-144517

Form 8-K - Current report:

SEC Accession No. 0001104659-16-144517

Filing Date

2016-09-14

Accepted

2016-09-14 08:10:32

Documents

Period of Report

2016-09-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a16-18504_18k.htm	8-K	39579
2	EX-2.1	a16-18504_1ex2d1.htm	EX-2.1	644864
3	EX-99.1	a16-18504_1ex99d1.htm	EX-99.1	32996
4	GRAPHIC	g185041mmi001.jpg	GRAPHIC	7609
5	GRAPHIC	g185041mmi002.jpg	GRAPHIC	6355
	Complete submission text file	0001104659-16-144517.txt		738267

Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034

Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000

Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36617 | Film No.: 161884201
SIC: 2834 Pharmaceutical Preparations